SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
XIE BING

(Last) (First) (Middle)
12500 TI BOULEVARD

(Street)
DALLAS TX 75243

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2015
3. Issuer Name and Ticker or Trading Symbol
TEXAS INSTRUMENTS INC [ TXN ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior Vice President
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 176,850(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
NQ Stock Option (Right to Buy) (2) 01/28/2020 Common Stock 1,875 23.05 D
NQ Stock Option (Right to Buy) (2) 01/28/2020 Common Stock 1,875 23.05 D
NQ Stock Option (Right to Buy) (3) 01/27/2021 Common Stock 7,500 34.63 D
NQ Stock Option (Right to Buy) (4) 01/26/2022 Common Stock 22,500 32.36 D
NQ Stock Option (Right to Buy) (5) 01/25/2023 Common Stock 40,000 32.8 D
NQ Stock Option (Right to Buy) (6) 01/23/2024 Common Stock 86,099 44.09 D
Explanation of Responses:
1. Includes 174,211 shares subject to terms of restricted stock units awarded under the 2009 Long-Term Incentive Plan.
2. The option becomes exercisable in four equal annual installments beginning on January 28, 2011.
3. The option becomes exercisable in four equal annual installments beginning on January 27, 2012.
4. The option becomes exercisable in four equal annual installments beginning on January 26, 2013.
5. The option becomes exercisable in four equal annual installments beginning on January 25, 2014.
6. The option becomes exercisable in four equal annual installments beginning on January 23, 2015.
/s/ Cynthia H. Grimm, Attorney In Fact 01/07/2015
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
EXHIBIT 24

                                 AUTHORIZATION

I hereby authorize Joseph F. Hubach, Cynthia H. Grimm, Daniel M. Drory,
Jane S. Nahra, and  Suzanne Thomas or any one of them to sign and file on
my behalf any and all forms required by the Securities and Exchange Commission
pursuant to Section 16 of the Securities Exchange Act of 1934 (the "Exchange
Act") relating to the reporting of beneficial ownership of equity securities
of Texas Instruments Incorporated (the "Company"), and of changes in such
beneficial ownership, as well as any and all representation letters that may
be required in connection with sales by me of equity securities of the
Company, together with any and all amendments to the foregoing.  This
authorization shall be effective on and after the date set forth below and
shall continue in effect until I am no longer required to file such forms
and letters, unless earlier revoked by me in writing.

I acknowledge that the persons authorized hereunder are not assuming, nor is
the Company assuming any of my responsibilities to comply with Section 16 of
the Exchange Act and other relevant securities laws.

Dated as of 17th day of December 2014.

/S/ Bing Xie